U.S. market Closed. Opens in 2 hours 23 minutes

IBRX | ImmunityBio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue622.00K240.00K934.00K605.00K2.20M47.00K45.00K44.00K236.00K641.00K
Cost of Revenue18.51M24.19MN/A9.15M9.01MN/AN/AN/AN/A323.00K
Gross Profit-17.89M-23.95M934.00K-8.54M-6.81M47.00KN/AN/AN/A318.00K
Operating Expenses343.47M350.86M331.21M210.82M158.45M98.44M99.17M124.54M239.11M5.92M
Selling, General & Admin129.62M102.71M135.26M71.32M46.46M42.72M57.12M95.39M227.68M4.33M
Research & Development213.85M248.15M195.96M139.51M112.00M55.72M42.04M29.15M11.43M1.59M
Other Operating Expenses-38.43M-736.00K193.00K1.49M-534.00KN/AN/AN/AN/AN/A
Operating Income-361.36M-351.30M-330.28M-220.88M-156.25M-96.30M-99.12M-124.50M-238.88M-5.60M
Other Expenses / Income-222.53M-65.99M-19.56M-5.15M-4.01M-433.00K2.20M3.12M1.70M-609.00K
Before Tax Income-583.89M-417.29M-349.84M-226.03M-160.26M-96.73M-96.92M-121.38M-237.18M-6.21M
Income Tax Expenses-40.00K34.00K9.00K-1.85M-105.00K-503.00K-493.00K-572.00K-301.00K1.00K
Net Income-583.20M-417.32M-349.85M-224.19M-160.16M-96.23M-96.42M-120.81M-236.88M-6.21M
Interest Expenses129.20M63.52M14.85M9.07M5.92M433.00K618.00K66.00KN/AN/A
Basic Shares Outstanding508.64M399.90M389.23M383.18M383.18M79.13M80.58M81.98M71.52M78.93M
Diluted Shares Outstanding508.64M399.90M389.23M383.18M383.18M79.13M80.58M81.98M71.52M78.93M
EBITDA-342.85M-343.98M-316.30M-195.13M-139.98M-86.74M-90.73M-117.71M-235.71M-6.08M
EBITDA Margin-55,120.90%-143,324.17%-33,865.52%-32,252.56%-6,356.77%-184,555.32%-201,626.67%-267,518.18%-99,875.00%-949.14%
EBIT-454.04M-353.77M-334.99M-216.96M-154.34M-96.30M-96.30M-121.31M-237.18M-6.21M
EBIT Margin-72,996.46%-147,404.58%-35,866.17%-35,860.99%-7,009.22%-204,885.11%-213,995.56%-275,715.91%-100,498.73%-969.11%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙